Pertussis immunization for adolescents: What are we waiting for?
作者信息
Halperin S A
机构信息
IWK-Grace Health Centre, Dalhousie University, Halifax, Nova Scotia.
出版信息
Can J Infect Dis. 2001 Mar;12(2):74-6. doi: 10.1155/2001/597063.
Abstract
摘要
相似文献
1
Pertussis immunization for adolescents: What are we waiting for?青少年百日咳免疫接种：我们还在等什么？
Can J Infect Dis. 2001 Mar;12(2):74-6. doi: 10.1155/2001/597063.
2
Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).预防青少年破伤风、白喉和百日咳：破伤风类毒素、白喉类毒素含量降低的无细胞百日咳疫苗的使用——免疫实践咨询委员会（ACIP）的建议
MMWR Recomm Rep. 2006 Mar 24;55(RR-3):1-34.
3
Pertussis-specific cell-mediated and humoral immunity in adolescents 3 years after booster immunization with acellular pertussis vaccine.青少年接种无细胞百日咳疫苗加强免疫3年后的百日咳特异性细胞免疫和体液免疫
Clin Infect Dis. 2004 Jul 15;39(2):179-85. doi: 10.1086/421943. Epub 2004 Jul 2.
4
Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations.无细胞百白破疫苗在风险人群（青少年、孕妇、新生儿和医护人员）中的使用：证据回顾与建议。
Vaccine. 2012 Jul 27;30(35):5179-90. doi: 10.1016/j.vaccine.2012.06.005. Epub 2012 Jun 15.
5
Pertussis immunization of adolescents in the United States: an economic evaluation.美国青少年百日咳免疫接种：一项经济学评估。
Pediatr Infect Dis J. 2005 May;24(5 Suppl):S75-82. doi: 10.1097/01.inf.0000160918.72953.51.
6
Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.青少年百日咳的预防：破伤风类毒素、白喉类毒素减少量及无细胞百日咳（Tdap）疫苗的使用建议
Pediatrics. 2006 Mar;117(3):965-78. doi: 10.1542/peds.2005-3038. Epub 2005 Dec 28.
7
Spotlight on Tdap₅ vaccine (Covaxis®) as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis: in children (aged ≥4 years), adolescents, and adults.聚焦 Tdap₅ 疫苗（Covaxis®）作为预防破伤风、白喉和百日咳的单一加强免疫接种：用于儿童（≥4 岁）、青少年和成人。
Paediatr Drugs. 2011 Apr 1;13(2):133-5. doi: 10.2165/11206990-000000000-00000.
8
Tdap5 vaccine (Covaxis): a review of its use as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis in children (aged 4 years), adolescents, and adults.Tdap5 疫苗（Covaxis）：作为一种单剂疫苗，用于预防儿童（4 岁）、青少年和成人破伤风、白喉和百日咳的用途综述。
BioDrugs. 2010 Dec 1;24(6):387-406. doi: 10.2165/11206000-000000000-00000.
9
Enhanced post-licensure safety surveillance of a new recombinant acellular pertussis vaccine licensed as a monovalent (aP, Pertagen®) and tetanus, reduced-dose diphtheria combination (TdaP, Boostagen®) vaccine for immunization of adolescents and adults in Thailand.在泰国，对一种新的无细胞百日咳重组疫苗进行上市后安全性强化监测，该疫苗作为单价（aP，Pertagen®）和破伤风、低剂量白喉联合疫苗（TdaP，Boostagen®）获得许可，用于青少年和成人的免疫接种。
Vaccine. 2020 Dec 3;38(51):8194-8199. doi: 10.1016/j.vaccine.2020.10.070. Epub 2020 Nov 8.
10
Pertussis immunization for adolescents: What are we waiting for?青少年百日咳免疫接种：我们还在等什么？
Paediatr Child Health. 2001 Apr;6(4):184-6. doi: 10.1093/pch/6.4.184.
引用本文的文献
1
Strategic Approaches Towards Pertussis Control in Oman.阿曼百日咳控制的战略方法。
Oman Med J. 2018 Jan;33(1):29-36. doi: 10.5001/omj.2018.06.
本文引用的文献
1
EPIDEMIOLOGY OF A SMALL PERTUSSIS OUTBREAK IN KENT COUNTY, MICHIGAN.密歇根州肯特县小规模百日咳疫情的流行病学情况
Public Health Rep (1896). 1965 Apr;80(4):365-9.
2
Pertussis is a frequent cause of prolonged cough illness in adults and adolescents.百日咳是成人和青少年长期咳嗽疾病的常见病因。
Clin Infect Dis. 2001 Jun 15;32(12):1691-7. doi: 10.1086/320754. Epub 2001 May 21.
3
4
Morbidity of pertussis in adolescents and adults.青少年和成人百日咳的发病率。
J Infect Dis. 2000 Jul;182(1):174-9. doi: 10.1086/315648. Epub 2000 Jun 30.
5
Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults.一种由无细胞百日咳疫苗、白喉和破伤风类毒素以及灭活脊髓灰质炎病毒疫苗组成的成人剂型疫苗，在青少年和成人中是安全且具有免疫原性的。
Pediatr Infect Dis J. 2000 Apr;19(4):276-83. doi: 10.1097/00006454-200004000-00003.
6
A randomised controlled trial with a diphtheria-tetanus-acellular pertussis (dTpa) vaccine in adults.一项针对成人的白喉-破伤风-无细胞百日咳（dTpa）疫苗的随机对照试验。
Vaccine. 2000 Apr 14;18(20):2075-82. doi: 10.1016/s0264-410x(99)00568-x.
7
Immune responses to pertussis antigens eight years after booster immunization with acellular vaccines in adults.
Vaccine. 2000 Apr 3;18(19):1971-4. doi: 10.1016/s0264-410x(99)00534-4.
8
An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults.一种与白喉和破伤风类毒素联合的五组分无细胞百日咳疫苗成人剂型在青少年和成人中是安全且具有免疫原性的。
Vaccine. 2000 Jan 31;18(14):1312-9. doi: 10.1016/s0264-410x(99)00415-6.
9
Evidence for transmission of pertussis in schools, Massachusetts, 1996: epidemiologic data supported by pulsed-field gel electrophoresis studies.1996年马萨诸塞州学校中百日咳传播的证据：脉冲场凝胶电泳研究支持的流行病学数据
J Infect Dis. 2000 Jan;181(1):210-5. doi: 10.1086/315192.
10
Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996.美国百日咳流行病学的变化：1990 - 1996年青少年和成人报告发病率上升
Clin Infect Dis. 1999 Jun;28(6):1230-7. doi: 10.1086/514776.
Zotero 插件